Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
havasu78's Profile
Displaying 201-250 of 491 result(s).
CYDY CytoDyn Inc
01/23/2021 3:57:52 PM
Quick google scholar search says ab (1)
CYDY CytoDyn Inc
01/23/2021 3:44:22 PM
Just wondering, why does it take 7 (1)
CYDY CytoDyn Inc
01/19/2021 3:58:09 PM
No effort to deceive. "We asked and (1)
CYDY CytoDyn Inc
01/19/2021 3:24:47 PM
Yes, I was aware that CYDY had cont
CYDY CytoDyn Inc
01/19/2021 3:07:15 PM
So the only way to get to intraveno (1)
CYDY CytoDyn Inc
01/19/2021 1:42:21 PM
Yes, the answer could be as simple (1)
CYDY CytoDyn Inc
01/19/2021 1:25:55 PM
The possibility that intravenous do (4)
CYDY CytoDyn Inc
01/13/2021 6:58:07 PM
yes, my bad, i paraphrased the stud
CYDY CytoDyn Inc
01/13/2021 6:48:02 PM
I agree. Published CCR5delta32 data
CYDY CytoDyn Inc
01/13/2021 6:46:16 PM
Certainly a good point that there a
CYDY CytoDyn Inc
01/13/2021 6:34:13 PM
My theory is that full immunity is
CYDY CytoDyn Inc
01/13/2021 6:23:05 PM
the peer review doesn't matter. the
CYDY CytoDyn Inc
01/13/2021 6:21:41 PM
There are no scientific studies to (1)
CYDY CytoDyn Inc
01/13/2021 6:08:59 PM
Yes, that's the main benefit I see.
CYDY CytoDyn Inc
01/13/2021 5:50:56 PM
That Africa study says "CCR5delta32
CYDY CytoDyn Inc
01/13/2021 5:41:07 PM
Perhaps we disagree as to the need
CYDY CytoDyn Inc
01/13/2021 4:13:48 PM
Thanks much, morokoy. An excellent (1)
CYDY CytoDyn Inc
01/13/2021 4:02:54 PM
Totally agree. In CD12 there are 39 (1)
CYDY CytoDyn Inc
01/13/2021 3:24:15 PM
Yes, CCR5delta32 mutation produces (1)
CYDY CytoDyn Inc
01/13/2021 3:11:37 PM
If CCR5 blockade is completely prot (1)
CYDY CytoDyn Inc
01/13/2021 2:36:41 AM
CCR5delta32 status should also be c (1)
CYDY CytoDyn Inc
01/13/2021 2:30:53 AM
I agree, 8% heterozyzous patients i (1)
CYDY CytoDyn Inc
01/13/2021 2:23:04 AM
No not a waste of time. If you test (4)
CYDY CytoDyn Inc
01/13/2021 2:03:22 AM
Oh sorry i get it now. LOL. protein
CYDY CytoDyn Inc
01/13/2021 1:56:31 AM
CCR5 is a g-coupled protein recepto (2)
CYDY CytoDyn Inc
01/13/2021 1:52:42 AM
Totally agree. all that matters now
CYDY CytoDyn Inc
01/13/2021 1:45:23 AM
"...immune to HIV infection. These
CYDY CytoDyn Inc
01/13/2021 1:34:51 AM
Sure phase 4 would be great for mor (1)
CYDY CytoDyn Inc
01/13/2021 1:28:29 AM
CCR5delta32 homozygous mutants do n
CYDY CytoDyn Inc
01/13/2021 1:21:15 AM
Suggestion to CYDY: Recast LL as a (2)
CYDY CytoDyn Inc
01/13/2021 1:14:36 AM
for all the complaining i have done (2)
CYDY CytoDyn Inc
01/13/2021 1:02:33 AM
Its not 44%, it could be 100%. Mayb (5)
CYDY CytoDyn Inc
01/13/2021 1:01:20 AM
So this study, which demonstrates t (3)
CYDY CytoDyn Inc
01/12/2021 1:46:59 AM
In particular, I think the potentia (2)
CYDY CytoDyn Inc
01/12/2021 1:28:11 AM
I believe CD12 will obtain covid EU (3)
CYDY CytoDyn Inc
01/11/2021 7:29:31 PM
This post by MDV brings to my mind (3)
CYDY CytoDyn Inc
01/11/2021 7:04:22 PM
If CD12 obtains EUA, CD12 RO is tot
CYDY CytoDyn Inc
01/11/2021 6:55:10 PM
It certainly could be true that the
CYDY CytoDyn Inc
01/11/2021 6:13:59 PM
By "squishy", I mean that CD12 prim (3)
CYDY CytoDyn Inc
01/11/2021 2:56:32 PM
Thanks ohm. I can see now that the
CYDY CytoDyn Inc
01/11/2021 1:56:24 PM
If there is no CCR5 RO test being p (2)
CYDY CytoDyn Inc
01/11/2021 4:52:43 AM
CYDY can see 100% of everything in
CYDY CytoDyn Inc
01/10/2021 9:37:06 PM
I remember Patterson saying many mo
CYDY CytoDyn Inc
01/10/2021 8:54:52 PM
CYDY has ALWAYS BEEN UNBLINDED on C (2)
CYDY CytoDyn Inc
01/08/2021 8:25:11 PM
hello to you, too, calstang. I too
CYDY CytoDyn Inc
01/08/2021 8:16:39 PM
No. i think 40 days for the 10Q fil
CYDY CytoDyn Inc
01/08/2021 3:44:03 PM
I think there is was no rush on 10Q
CYDY CytoDyn Inc
01/08/2021 3:39:47 PM
Is 80% power a normal number? And j
CYDY CytoDyn Inc
01/08/2021 3:02:14 PM
LOL. M/M was indeed phase 2. I will
CYDY CytoDyn Inc
01/08/2021 2:56:59 PM
Thanks, ohm. thats all very logical (2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Marjorie Taylor Greene's Shift: Health Care Talks with Democrats
  • ARGAN and Danone Forge New Logistics Milestone at Sorigny
  • Key Stocks Surge: James Hardie, AMD, Trilogy Metals, and More
  • Albion Technology Updates Share Buyback and Voting Rights
  • Celebrating the 300th Rafale: A Testament to Success
  • NVIDIA vs Competitors: An In-Depth Semiconductor Market Analysis
  • PayPal Announces UPI Partnership, Boosting Payment Solutions Globally
  • Dell Technologies Sees Growth and Future Expansion Plans
  • Innovative Collaboration for Carbon Disclosure Standards
  • Potential Winners in the Metal Stock Market Amid Policy Shifts
  • Empowering Future Female Technicians with Advanced Tools
  • Jury Delivers $61 Million Verdict Against Honda: A Tragic Case
  • The Rising Horizon of Rheumatoid Arthritis Drug Market Growth
  • WaveBreak Unveils Groundbreaking Data for Parkinson's Treatment
  • Students for Fair Admissions Takes Legal Action Against Coast Guard
  • Campaign Aims to Highlight Value of Local Franchise Owners
  • Defender Capital Raises Concerns Over STAAR Surgical and Alcon Deal
  • The Importance of Power Washing for Property Managers' Budgets
  • Baltic SF VIII Limited Finalizes Sale of Cargo Vessel Sailor
  • EeroQ's CEO Celebrated in Chicago's 40 Under 40 Honorees
  • Tend's Innovative Dentist Pay Structure: Transforming Careers
  • Roth Staffing Companies Celebrates Top Workplaces Recognition
  • Andrew Yorks Takes the Helm at Transamerica's Investment Division
  • Standard Textile Partners with Accor for Luxury Linen Collection
  • William J. Lee's Elevation to Fellow of the Epidemiology College
  • Explore Rob Zombie's Unique Art Exhibition in Kent Connetcticut
  • Chicken Salad Chick Expands with New Franchise Agreements
  • Commitment to Sustainability in Chianti Classico Wine Region
  • Crunch Lab Secures $5M Investment to Revolutionize AI Solutions
  • Impact of Financial Status on Longevity Among Older Adults
  • Travel Guard's Search for the World's Most Unfortunate Traveler
  • Evaluating Microsoft and Its Competitors in Software Market
  • Empowering Marketing: The FQ and Rokt Unveil New Series
  • Investing Insights: Meta Platforms and Its Competitors
  • Cavender's Expands Seasonal Hiring for Festive Period Ahead
  • Analyzing Yum Brands: Insights on Stock Performance and P/E Ratio
  • IotaComm® Strengthens Leadership to Propel Growth and Innovation
  • Explore Critical Themes at the 2025 Housing Tax Credit Conference
  • House of Dank Launches Massive Daily Cannabis Giveaway
  • Douglas Elliman's Innovative AI Platform Transforms Real Estate
  • Collaborative Efforts in Carbon Disclosure by Leading Organizations
  • Rising Costs Ignite Demand for Immediate Rent Controls
  • Avy Mallik Joins Morrison Foerster as Key Partner in Growth
  • Transforming Lives: The Mission Behind Safe Path Indy Housing
  • The Barnes Global Advisors Welcomes Jesse Geisbert to Team
  • Adlib's Renewed Compliance Solidifies Document Transformation Trust
  • Evaluating Amazon.com and Its Rivals in Retail Sector Insights
  • PurposeCare of Ohio: Elevating Home Care Services for Families
  • Exploring the Expanding Neuromuscular Disease Therapeutics Market
  • Evaluating Apple Inc's Performance Among Industry Giants
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site